In July, Pacific Biosciences secured $100 million in a
Series E private equity financing round.
In July, Pacific Biosciences secured $100 million in a Series E
private equity financing round to develop its SMRT (single-molecular,
real-time) DNA sequencing platform. The round was led by Deerfield
Capital Management and Intel Capital.
COPYRIGHT 2008 Strategic Directions International
Inc. (SDI) Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.